Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Imbalances in the composition and number of bacteria in the gut microbiota have been implicated in inflammatory bowel disease (IBD), and modulation of the gut microbiota by probiotics and antibiotics in IBD has been an active area of research, with mixed results. This narrative review summarizes the findings of relevant publications identified using the PubMed database. Although antibiotics have been associated with an increased risk of IBD development and flares, several meta-analyses demonstrate that antibiotics are efficacious for the induction of remission and treatment of flares in patients with IBD. Data supporting their use include a large number of antibiotic studies in Crohn's disease and evidence suggests antibiotics are efficacious in both Crohn's disease and ulcerative colitis, although there are fewer studies of the latter. For Crohn's disease, antibiotics have been shown to be useful for the induction of remission and in the postoperative management of patients undergoing surgery. Additionally, patients with fistulizing disease, particularly perianal, can benefit from antibiotics administered short term. Both antimicrobials and probiotics have been shown to be useful for the treatment of pouchitis. Additional randomized controlled trials are needed to further elucidate the role of bacteria in IBD and to better inform clinicians about appropriate antibiotic therapies.

Original languageEnglish
Pages (from-to)7-19
Number of pages13
JournalPostgraduate Medicine
Volume126
Issue number4
DOIs
StatePublished - Jan 1 2014

Fingerprint

Disease Management
Inflammatory Bowel Diseases
Anti-Bacterial Agents
Crohn Disease
Remission Induction
Probiotics
Pouchitis
Bacteria
Gastrointestinal Microbiome
Ulcerative Colitis
PubMed
Publications
Meta-Analysis
Therapeutics
Randomized Controlled Trials
Databases
Research

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Gut microbiota and inflammatory bowel disease : the role of antibiotics in disease management. / Kerman, David H; Deshpande, Amar R.

In: Postgraduate Medicine, Vol. 126, No. 4, 01.01.2014, p. 7-19.

Research output: Contribution to journalArticle

@article{1448ac8ee26048d3a9472d6aab87c168,
title = "Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management.",
abstract = "Imbalances in the composition and number of bacteria in the gut microbiota have been implicated in inflammatory bowel disease (IBD), and modulation of the gut microbiota by probiotics and antibiotics in IBD has been an active area of research, with mixed results. This narrative review summarizes the findings of relevant publications identified using the PubMed database. Although antibiotics have been associated with an increased risk of IBD development and flares, several meta-analyses demonstrate that antibiotics are efficacious for the induction of remission and treatment of flares in patients with IBD. Data supporting their use include a large number of antibiotic studies in Crohn's disease and evidence suggests antibiotics are efficacious in both Crohn's disease and ulcerative colitis, although there are fewer studies of the latter. For Crohn's disease, antibiotics have been shown to be useful for the induction of remission and in the postoperative management of patients undergoing surgery. Additionally, patients with fistulizing disease, particularly perianal, can benefit from antibiotics administered short term. Both antimicrobials and probiotics have been shown to be useful for the treatment of pouchitis. Additional randomized controlled trials are needed to further elucidate the role of bacteria in IBD and to better inform clinicians about appropriate antibiotic therapies.",
author = "Kerman, {David H} and Deshpande, {Amar R}",
year = "2014",
month = "1",
day = "1",
doi = "10.3810/pgm.2014.07.2779",
language = "English",
volume = "126",
pages = "7--19",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "4",

}

TY - JOUR

T1 - Gut microbiota and inflammatory bowel disease

T2 - the role of antibiotics in disease management.

AU - Kerman, David H

AU - Deshpande, Amar R

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Imbalances in the composition and number of bacteria in the gut microbiota have been implicated in inflammatory bowel disease (IBD), and modulation of the gut microbiota by probiotics and antibiotics in IBD has been an active area of research, with mixed results. This narrative review summarizes the findings of relevant publications identified using the PubMed database. Although antibiotics have been associated with an increased risk of IBD development and flares, several meta-analyses demonstrate that antibiotics are efficacious for the induction of remission and treatment of flares in patients with IBD. Data supporting their use include a large number of antibiotic studies in Crohn's disease and evidence suggests antibiotics are efficacious in both Crohn's disease and ulcerative colitis, although there are fewer studies of the latter. For Crohn's disease, antibiotics have been shown to be useful for the induction of remission and in the postoperative management of patients undergoing surgery. Additionally, patients with fistulizing disease, particularly perianal, can benefit from antibiotics administered short term. Both antimicrobials and probiotics have been shown to be useful for the treatment of pouchitis. Additional randomized controlled trials are needed to further elucidate the role of bacteria in IBD and to better inform clinicians about appropriate antibiotic therapies.

AB - Imbalances in the composition and number of bacteria in the gut microbiota have been implicated in inflammatory bowel disease (IBD), and modulation of the gut microbiota by probiotics and antibiotics in IBD has been an active area of research, with mixed results. This narrative review summarizes the findings of relevant publications identified using the PubMed database. Although antibiotics have been associated with an increased risk of IBD development and flares, several meta-analyses demonstrate that antibiotics are efficacious for the induction of remission and treatment of flares in patients with IBD. Data supporting their use include a large number of antibiotic studies in Crohn's disease and evidence suggests antibiotics are efficacious in both Crohn's disease and ulcerative colitis, although there are fewer studies of the latter. For Crohn's disease, antibiotics have been shown to be useful for the induction of remission and in the postoperative management of patients undergoing surgery. Additionally, patients with fistulizing disease, particularly perianal, can benefit from antibiotics administered short term. Both antimicrobials and probiotics have been shown to be useful for the treatment of pouchitis. Additional randomized controlled trials are needed to further elucidate the role of bacteria in IBD and to better inform clinicians about appropriate antibiotic therapies.

UR - http://www.scopus.com/inward/record.url?scp=84907960361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907960361&partnerID=8YFLogxK

U2 - 10.3810/pgm.2014.07.2779

DO - 10.3810/pgm.2014.07.2779

M3 - Article

C2 - 25141239

AN - SCOPUS:84907960361

VL - 126

SP - 7

EP - 19

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 4

ER -